Correlation Between Cognition Therapeutics and Minerva Neurosciences
Can any of the company-specific risk be diversified away by investing in both Cognition Therapeutics and Minerva Neurosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cognition Therapeutics and Minerva Neurosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cognition Therapeutics and Minerva Neurosciences, you can compare the effects of market volatilities on Cognition Therapeutics and Minerva Neurosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cognition Therapeutics with a short position of Minerva Neurosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cognition Therapeutics and Minerva Neurosciences.
Diversification Opportunities for Cognition Therapeutics and Minerva Neurosciences
0.34 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Cognition and Minerva is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding Cognition Therapeutics and Minerva Neurosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Minerva Neurosciences and Cognition Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cognition Therapeutics are associated (or correlated) with Minerva Neurosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Minerva Neurosciences has no effect on the direction of Cognition Therapeutics i.e., Cognition Therapeutics and Minerva Neurosciences go up and down completely randomly.
Pair Corralation between Cognition Therapeutics and Minerva Neurosciences
Given the investment horizon of 90 days Cognition Therapeutics is expected to under-perform the Minerva Neurosciences. In addition to that, Cognition Therapeutics is 1.61 times more volatile than Minerva Neurosciences. It trades about -0.18 of its total potential returns per unit of risk. Minerva Neurosciences is currently generating about -0.08 per unit of volatility. If you would invest 246.00 in Minerva Neurosciences on August 28, 2024 and sell it today you would lose (20.00) from holding Minerva Neurosciences or give up 8.13% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cognition Therapeutics vs. Minerva Neurosciences
Performance |
| Timeline |
| Cognition Therapeutics |
| Minerva Neurosciences |
Cognition Therapeutics and Minerva Neurosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cognition Therapeutics and Minerva Neurosciences
The main advantage of trading using opposite Cognition Therapeutics and Minerva Neurosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cognition Therapeutics position performs unexpectedly, Minerva Neurosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Minerva Neurosciences will offset losses from the drop in Minerva Neurosciences' long position.| Cognition Therapeutics vs. Reviva Pharmaceuticals Holdings | Cognition Therapeutics vs. Eyenovia | Cognition Therapeutics vs. Transcode Therapeutics | Cognition Therapeutics vs. Kodiak Sciences |
| Minerva Neurosciences vs. Reviva Pharmaceuticals Holdings | Minerva Neurosciences vs. Eyenovia | Minerva Neurosciences vs. Cognition Therapeutics | Minerva Neurosciences vs. Transcode Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |